Jonathan P. Divincenzo
CIK 1453524 · View on SEC EDGAR ↗
First SEC filing: Sept. 17, 2024 · Latest: Sept. 17, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 21, 2024 | LH | S | 500 | $215.49 | $107,745 | 3,401 Direct | -12.82% | Disposed | 54.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (4,863) | $256.45 | March 3, 2035 | 4,863 | Acquired |
| Oct. 24, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (7,478) | — | — | 7,478 | Acquired |
| March 27, 2024 | LH | Restricted Stock Unit | Common Stock (3,012) | — | — | 3,012 | Disposed |
| Feb. 11, 2024 | LH | Restricted Stock Unit | Common Stock (201) | — | — | 201 | Disposed |
| Feb. 7, 2024 | LH | Restricted Stock Unit | Common Stock (138) | — | — | 138 | Disposed |
| Feb. 7, 2024 | LH | Restricted Stock Unit | Common Stock (224) | — | — | 224 | Disposed |
| Feb. 6, 2024 | LH | Non-qualified Stock Options [F5] | Common Stock (3,000) | $222.28 | Feb. 5, 2034 | 3,000 | Acquired |
| Feb. 6, 2024 | LH | Restricted Stock Unit | Common Stock (980) | — | — | 980 | Acquired |
| Feb. 2, 2024 | LH | Restricted Stock Unit | Common Stock (246) | — | — | 246 | Disposed |
| Dec. 15, 2023 | LH | Restricted Stock Unit | Common Stock (64) | — | — | 64 | Disposed |
| June 30, 2023 | LH | Restricted Stock Unit | Common Stock (3,036) | — | — | 3,036 | Acquired |
| May 5, 2023 | LH | Restricted Stock Unit | Common Stock (370) | — | — | 370 | Acquired |
| May 5, 2023 | LH | Non-qualified Stock Options [F1] | Common Stock (1,200) | $223.86 | May 4, 2033 | 1,200 | Acquired |
| Feb. 9, 2016 | RVTY | NQ Stock Option (right to buy) | Common Stock (31,917) | $42.47 | Feb. 9, 2023 | 31,917 | Acquired |
| Feb. 3, 2015 | RVTY | NQ Stock Option (right to buy) | Common Stock (26,667) | $46.83 | Feb. 3, 2022 | 26,667 | Acquired |
| Feb. 4, 2014 | RVTY | NQ Stock Option (right to buy) | Common Stock (22,542) | $43.01 | Feb. 4, 2021 | 22,542 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 17, 2024 | BIO | No securities beneficially owned | 0 | Direct |
| May 8, 2023 | LH | Common Stock | 3,290 | Direct |
| May 8, 2023 | LH | Restricted Stock Unit→ Common Stock (220) | 220 | Direct |
| May 8, 2023 | LH | Restricted Stock Unit→ Common Stock (114) | 114 | Direct |
| May 8, 2023 | LH | Restricted Stock Unit→ Common Stock (600) | 600 | Direct |
| May 8, 2023 | LH | Restricted Stock Unit→ Common Stock (360) | 360 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BIO
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $673,208 | — | — | — | $476,702 | — | $23,044 | $3,680,772 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $352,692 | — | — | — | — | — | $777,814 | $1,733,139 |
| 2015 | $427,692 | — | — | — | $277,816 | — | $16,740 | $1,308,933 |
| 2014 | $400,000 | — | — | — | $294,600 | — | $18,350 | $1,246,246 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.